The 1996 Moyer Award: Effects of endotoxin on the Th1/Th2 response in humans

Journal of Burn Care and Rehabilitation

Volumn 17, Issue 6, 1996, Pages 491-496

  Zimmer, S ^a   Pollard, V ^b   Marshall, G D ^b   Garofalo, R P ^b   Traber, D ^b   Prough, D ^b   Herndon, D N ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6;

ADULT; ARTICLE; CELL INTERACTION; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION; MALE; NORMAL HUMAN; PATHOPHYSIOLOGY; SEPSIS; T LYMPHOCYTE;

EID: 0029844968     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199611000-00004     Document Type: Article

References (39)

1. Levin P, Poore TE, Zauber NP. Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria. N Engl J Med 1970;283:1313-6.
2. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988b;318:1481-6.
3. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321:280-7.
4. Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology 1993;187:403-16.
5. Mosmann TR,Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins. Immunology 1986;136:2348-57.
6. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991;12:256-7.
7. Cher DJ, Mosmann TR. Two types of murine helper T cell clones. II. Delayed type hypersensitivity is mediated through Th1 clones. Immunology 1987;138:3688-94.
8. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties [Review]. Ann Rev Immunol 1989;7:145-73.
9. Finkelman FD, Pearce EJ, Urban J Jr, Sher A. Regulation and biological function of helminth-induced cytokine responses [Review]. Immunol Today 1991;12:A62-6.
10. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
11. Rook GA, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994;15:301-3.
12. Howard M, O'Garra A. Biological properties of IL-10. Immunol Today 1992;13:198-200.
13. Vieira P, de Waal Malefyt R, Dang MN, et al. Isolation and expression of human cytokine synthesis inhibitor factor (CSIF/IL-10) CDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl Acad Sci U S A 1991;88:1171-6.
14. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
15. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. Interleukin-10 (IL-10) inhibits cytokine by activated monocytes. J Immunol 1991;147:385-422.
16. Gomez-Jimenez J, Martin MC, Sauri R, et al. Interleukin-10 and the monocyte and/or macrophage-induced inflammatory response in septic shock. Infect Dis 1995;171:472-5.
17. Marchant A, Deviere J, Byl B, De Groote D, Vincent JL, Goldman M. Interleukin-10 production during septicemia. Lancet 1994;343:707-8.
18. Van der Poll T, Jansen J, Levi M, Ten Gate H, Ten Gate JW, Van Deventer SJ. Regulation of interleukin-10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994;180:1985-8.
19. Wanidworanum C, Strober W. Predominant role of tumor necrosis factor alpha in human IL-10 synthesis. J Immunol 1993;151:6853-61.
20. Ayala A, Lehman DL, Herdon CD, Chaudry IH. Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T cell response is mediated by eicosanoid-induced interleukin-4 release. Arch Surg 1994; 129:1172-8.
21. Meakins JL, Christou NV, Shizgath M, Macklin AP. Therapeutic approaches to aim anergy in surgical patients: surgery and lephaminzol. Ann Surg 1979;190:286-96.
22. Smith KA. Interleukin-2: inception, impact, and implications. Science 1988;240:1169-76.
23. Timonen T, Ranki A, Saksela E. Human natural cell-mediated cytotoxicity against fetal fibroblasts. III. Morphological and functional characterization of the effector cells. Cell Immunol 1979;48:121-32.
24. Kashara T, Djeu JY, Dougherty SF, et al. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: IL-2, interferon and colony-stimulation-factor. J Immunol 1983;131:2379-85.
25. Billiau A, Dijkmans R. Interferon-gamma: mechanism of action and therapeutic potential. Biochem Pharmacol 1990;40: 1433-9.
26. Ijzermans JN, Marquet RL. Interferon-gamma: a review. Immunobiology 1989;179:456-73.
27. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Med 1991;173:869-79.
28. D'Andrea A, Rengaraju M, Valiante NM, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Med 1992;176:1387-98.
29. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-9.
30. Locksley RM. Interleukin 12 in host defense against microbial pathogens [comment]. Proc Natl Acad Sci USA 1993; 90:5879-80.
31. Scott P. IL-12: initiation cytokine for cell-mediated immunity [comment]. [Review]. Science 1993;260:496-7.
32. Trinchieri G, Wysocka M, D'Andrea A, et al. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. [Review]. Prog Growth Factor Res 1992;4:355-68.
33. Faist E, Mewes A, Strasser T, et al. Alterations of monocyte function following major injury. Arch Surg 1988;23:287-93.
34. Cahill J, Hopper KE. Immunoregulation by macrophages: differential secretion of prostaglandin E2 and interleukin during infection with Salmonella enteritidis. Cell Immunol 1982; 67:229-40.
35. Faist E, Mewes A, Baker CC. Prostaglandin E2 (PGE2)-dependent suppression of interleukin-2 (IL-2) production in patients with major trauma. J Trauma 1987;27:837-48.
36. Choudhry MA, Ahmad S, Sayeed MM. Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis. Infect Immunol 1995;63:3101-5.
37. van der Pouw Kraan TC, Boeije LC, Smeek RJ, Wijdenes J, Aarden LA. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995;181:775-9.
38. Kalinski P, Hilkens CM, Wierenga EA, et al. Functional maturation of human T helper cells in the absence of accessory cells. J Immunol 1995;154:3753-60.
39. King CL, Stupi RJ, Craighead N, June CH, Thyphronitis G. CD28 activation promotes subset differentiation by human CD4+ cells. Eur J Immunol 1995;25:587-95.